Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort

SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring

Rosa, G. L., Mancini, P., Ferraro, G. B., Veneri, C., Iaconelli, M., Bonadonna, L., Lucentini, L., & Suffredini, E. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141711 · Cited by 349 · see citing works

The French CONSTANCES population-based cohort: design, inclusion and follow-up

CONSTANCES team, Zins, M., & Goldberg, M. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0096-4 · Cited by 283 · see citing works

SARS-CoV-2 was already spreading in France in late December 2019

Deslandes, A., Berti, V., Tandjaoui-Lambiotte, Y., Alloui, C., Carbonnelle, É., Zahar, J., Brichler, S., & Cohen, Y. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106006 · Cited by 243 · see citing works

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy

Apolone, G., Montomoli, E., Manenti, A., Boeri, M., Sabia, F., Hyseni, I., Mazzini, L., Martinuzzi, D., Cantone, L., Milanese, G., et al. (2021) · Tumori Journal · doi:10.1177/0300891620974755 · Cited by 166 · see citing works

Validation of a commercially available SARS-CoV-2 serological immunoassay

Meyer, B., Torriani, G., Yerly, S., Mazza, L., Calame, A., Arm‐Vernez, I., Zimmer, G., Agoritsas, T., Stirnemann, J., Spechbach, H., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.024 · Cited by 156 · see citing works

Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors

Gallian, P., Pastorino, B. A. M., Morel, P., Chiaroni, J., Ninove, L., & de Lamballerie, X. N. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104880 · Cited by 138 · see citing works

SARS-CoV-2 has been circulating in northern Italy since December 2019: evidence from environmental monitoringPreprint

Rosa, G. L., Mancini, P., Ferraro, G. B., et al. (2020) · medRxiv · doi:10.1101/2020.06.25.20140061 · Cited by 59 · see citing works

Validation of a commercially available SARS-CoV-2 serological ImmunoassayPreprint

Meyer, B., Torriani, G., Yerly, S., Mazza, L., Calame, A., Arm‐Vernez, I., Zimmer, G., Agoritsas, T., Stirnemann, J., Spechbach, H., et al. (2020) · medRxiv · doi:10.1101/2020.05.02.20080879 · Cited by 32 · see citing works

Hospital and Population-Based Evidence for COVID-19 Early Circulation in the East of France

Gerbaud, L., Guiguet‐Auclair, C., Breysse, F., Odoul, J., Ouchchane, L., Peterschmitt, J., Dezfouli-Desfer, C., & Breton, V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197175 · Cited by 30 · see citing works

The Lancet Commission on lessons for the future from the COVID-19 pandemic

Sachs, J. D., Karim, S. S. A., Aknin, L., Allen, J., Brosbøl, K., Colombo, F., Barron, G. C., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01585-9 · Cited by 842 · see citing works

Surveillance of SARS-CoV-2 at the Huanan Seafood Market

Gao, G. F., Liu, P., Liu, P., Lei, W., Jia, Z., He, X., Liu, L.-L., Shi, W., Tan, Y., 邹淑梅, et al. (2023) · Nature · doi:10.1038/s41586-023-06043-2 · Cited by 136 · see citing works

The origins of COVID‐19 pandemic: A brief overview

Hao, Y., Wang, Y., Wang, M.-Y., Zhou, L., Shi, J., Cao, J., & Wang, D. (2022) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14732 · Cited by 103 · see citing works

Where did COVID come from? Five mysteries that remain

Mallapaty, S. (2021) · Nature · doi:10.1038/d41586-021-00502-4 · Cited by 43 · see citing works

Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain

Saeed, N. K., Alkhawaja, S. A., Alsalman, J., Almusawi, S., AlBalooshi, N., & Al‐Beltagi, M. (2021) · World Journal of Virology · doi:10.5501/wjv.v10.i4.168 · Cited by 36 · see citing works

Early detection of emerging infectious diseases - implications for vaccine development

MacIntyre, C. R., Lim, S., Gurdasani, D., Miranda, M., Metcalf, D. H., Quigley, A. L., Hutchinson, D., Burr, A., & Heslop, D. J. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.05.069 · Cited by 32 · see citing works

Molecular evidence for SARS-CoV-2 in samples collected from patients with morbilliform eruptions since late 2019 in Lombardy, northern Italy

Amendola, A., Canuti, M., Bianchi, S., Kumar, S., Fappani, C., Gori, M., Colzani, D., Pond, S. L. K., Miura, S., Baggieri, M., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113979 · Cited by 25 · see citing works

SARS-CoV-2's origin should be investigated worldwide for pandemic prevention

Wu, Z., Jin, Q., Wu, G., Lu, J., Li, M., Guo, D., Lan, K., Feng, L., Qian, Z., Ren, L., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02020-1 · Cited by 23 · see citing works

Use of a risk assessment tool to determine the origin of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)

Chen, X., Kalyar, F., Chughtai, A. A., & MacIntyre, C. R. (2024) · Risk Analysis · doi:10.1111/risa.14291 · Cited by 20 · see citing works

Delay-differential SEIR modeling for improved modelling of infection dynamics

Kiselev, I. N., Akberdin, I. R., & Kolpakov, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-40008-9 · Cited by 32 · see citing works

Tracing the origin of Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2): A systematic review and narrative synthesis

Thakur, N. N., Das, S., Kumar, S., Maurya, V. K., Dhama, K., Paweska, J. T., Abdel-Moneim, A. S., Jain, A., Tripathi, A. K., Puri, B., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28060 · Cited by 18 · see citing works

Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients

Dupont, A., Couffignal, C., Arias, C., Sallah, K., Phillips-Houlbracq, M., Brun, M. L., & Taillé, C. (2022) · Respiratory Research · doi:10.1186/s12931-022-02265-6 · Cited by 18 · see citing works

Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom

Chappell, J. G., Tsoleridis, T., Clark, G., Berry, L., Holmes, N., Moore, C., Carlile, M., Sang, F., Debebe, J., Wright, V. J., et al. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001595 · Cited by 18 · see citing works

COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective

Cavaillon, J.-M., & Osuchowski, M. F. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.04.003 · Cited by 17 · see citing works

Monitoring the propagation of SARS CoV2 variants by tracking identified mutation in wastewater using specific RT-qPCRPreprint

Wurtzer, S., Waldman, P., Levert, M., Mouchel, J., Gorgé, O., Boni, M., Maday, Y., Maréchal, V., & Moulin, L. (2021) · medRxiv · doi:10.1101/2021.03.10.21253291 · Cited by 16 · see citing works

The East–West divide in response to COVID-19

Jamison, D. T., & Wu, K. B. (2021) · Engineering · doi:10.1016/j.eng.2021.05.008 · Cited by 16 · see citing works

Waiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence?

Canuti, M., Bianchi, S., Kolbl, O., Pond, S. L. K., Kumar, S., Gori, M., Fappani, C., Colzani, D., Borghi, E., Zuccotti, G., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-008386 · Cited by 15 · see citing works

Nationwide increases in anti-SARS-CoV-2 IgG antibodies between October 2020 and March 2021 in the unvaccinated Czech population

Piler, P., Thon, V., Andrýsková, L., Doležel, K., Kostka, D., Pavlík, T., Dušek, L., Pikhart, H., Bobák, M., Matić, S., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00080-0 · Cited by 15 · see citing works

Phylogenetic reconstruction of the initial stages of the spread of the SARS-CoV-2 virus in the Eurasian and American continents by analyzing genomic data

Bukin, Y. S., Bondaryuk, A. N., Kulakova, N. V., Балахонов, С. В., Dzhioev, Y. P., & Zlobin, V. I. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198551 · Cited by 15 · see citing works

Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting

Montomoli, E., Apolone, G., Manenti, A., Boeri, M., Suatoni, P., Sabia, F., Marchianò, A. V., Bollati, V., Pastorino, U., & Sozzi, G. (2021) · Viruses · doi:10.3390/v14010061 · Cited by 13 · see citing works

Evidence of SARS-CoV-2 Antibodies and RNA on Autopsy Cases in the Pre-Pandemic Period in Milan (Italy)

Lai, A., Tambuzzi, S., Bergna, A., Battistini, A., Ventura, C. D., Galli, M., Zoja, R., Zehender, G., & Cattaneo, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.886317 · Cited by 12 · see citing works

Peptide microarray IgM and IgG screening of pre-SARS-CoV-2 human serum samples from Zimbabwe for reactivity with peptides from all seven human coronaviruses: a cross-sectional study

Ashworth, J., Mathie, D., Scott, F., Mahendran, Y., Woolhouse, M. E. J., Stoevesandt, O., Mduluza, T., & Mutapi, F. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00295-6 · Cited by 12 · see citing works

Emergence of SARS and COVID-19 and preparedness for the next emerging disease X

Hu, B., Guo, H., Si, H., & Shi, Z. (2024) · Frontiers in Medicine · doi:10.1007/s11684-024-1066-6 · Cited by 10 · see citing works

The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment

AlMalki, F. A., Albukhaty, S., Alyamani, A. A., Khalaf, M. N., & Thomas, S. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-18868-x · Cited by 11 · see citing works

Association between COVID-19 infection and work exposure assessed by the Mat-O-Covid job exposure matrix in the CONSTANCES cohort

Fadel, M., Gilbert, F., Legeay, C., Dubée, V., Esquirol, Y., Verdun-Esquer, C., Dinh, A., Sembajwe, G. N., Goldberg, M., Roquelaure, Y., et al. (2022) · Occupational and Environmental Medicine · doi:10.1136/oemed-2022-108436 · Cited by 11 · see citing works

Molecular Evidence for SARS-CoV-2 in Samples Collected From Patients With Morbilliform Eruptions Since Late Summer 2019 in Lombardy, Northern ItalyPreprint

Amendola, A., Canuti, M., Bianchi, S., Kumar, S., Fappani, C., Gori, M., Colzani, D., Pond, S. L., Miura, S., Baggieri, M., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3883274 · Cited by 11 · see citing works

Prospective Metabolomic Studies in Precision Medicine: The AKRIBEA Project

Bizkarguenaga, M., Gil‐Redondo, R., Bruzzone, C., Bernardo‐Seisdedos, G., Laín, A., González‐Valle, B., Embade, N., Mato, J. M., & Millet, Ó. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_610 · Cited by 10 · see citing works

Major interregional differences in France of COVID-19 hospitalization and mortality from January to June 2020

Muller, J., Loc, P. T. B., Binder-Foucard, F., Borde, A., Bruandet, A., Bourhis-Zaimi, M. L., Lenne, X., Ouattara, E. N., Séguret, F., Gilleron, V., et al. (2022) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2022.08.008 · Cited by 10 · see citing works

Analysis of the Genomic Distance Between Bat Coronavirus RaTG13 and SARS-CoV-2 Reveals Multiple Origins of COVID-19

Pei, S., & Yau, S. S. ‐. (2021) · Acta Mathematica Scientia · doi:10.1007/s10473-021-0323-x · Cited by 10 · see citing works

Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

Liu, J., Chen, X., Liu, Y., Lin, J., Shen, J., Zhang, H., Yin, J., Pu, R., Ding, Y., & Cao, G. (2021) · Infectious Diseases of Poverty · doi:10.1186/s40249-021-00895-4 · Cited by 10 · see citing works

A Delay Differential Equation approach to model the COVID-19 pandemicPreprint

Kiselev, I. N., Akberdin, I. R., & Kolpakov, F. (2021) · medRxiv · doi:10.1101/2021.09.01.21263002 · Cited by 10 · see citing works

The benefit of augmenting open data with clinical data-warehouse EHR for forecasting SARS-CoV-2 hospitalizations in Bordeaux area, France

Ferté, T., Jouhet, V., Griffier, R., Hejblum, B. P., Thiébaut, R., Faure, I., Revel, P., Tentillier, E., Dindart, J.-M., Gruson, D., et al. (2022) · JAMIA Open · doi:10.1093/jamiaopen/ooac086 · Cited by 8 · see citing works

Covid-19: Early Cases and Disease Spread

Reis, J. J., Faou, A. L., Buguet, A., Sandner, G., & Spencer, P. S. (2022) · Annals of Global Health · doi:10.5334/aogh.3776 · Cited by 8 · see citing works

Early Evidence of Circulating SARS-CoV-2 in Unvaccinated and Vaccinated Measles Patients, September 2019–February 2020

Paixao, J., Galangue, M., Gaston, C., Carralero, R., Lino, C., Júlio, G., David, Z., Francisco, M., Sebastião, C. S., Sacomboio, E. N., et al. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s344437 · Cited by 7 · see citing works

A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?

Trombetta, C. M., Marchi, S., Viviani, S., Manenti, A., Casa, E., Dapporto, F., Remarque, E. J., Bollati, V., Manini, I., Lazzeri, G., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2047582 · Cited by 7 · see citing works

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)

Hofman, P. M., Bordone, O., Chamorey, E., Benzaquen, J., Schiappa, R., Lespinet‐Fabre, V., Lantéri, E., Brest, P., Mograbi, B., Maniel, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.730577 · Cited by 7 · see citing works

Wars and sweets: microbes, medicines and other moderns in and beyond the(ir) antibiotic era

Hutchison, C. D. L. (2022) · Medical Humanities · doi:10.1136/medhum-2021-012366 · Cited by 6 · see citing works

A Pictorial Essay Describing the CT Imaging Features of COVID-19 Cases throughout the Pandemic with a Special Focus on Lung Manifestations and Extrapulmonary Vascular Abdominal Complications

Brogna, B., Bignardi, E., Megliola, A., Laporta, A., Rocca, A. L., Volpe, M., & Musto, L. A. (2023) · Biomedicines · doi:10.3390/biomedicines11082113 · Cited by 6 · see citing works

Early Circulation of SARS-CoV-2, Congo, 2020

Bonguili, N. C. B., Fritz, M., Lenguiya, L. H., Mayengué, P. I., Koukouikila-Koussounda, F., Dossou-Yovo, L. R., Badzi, C. N., Leroy, E. M., & Niama, F. R. (2022) · Emerging infectious diseases · doi:10.3201/eid2804.212476 · Cited by 6 · see citing works

Comparative and quantitative analysis of COVID-19 epidemic interventions in Chinese provinces

Liu, H., Rong, Z., Qi, X., Fu, J., Huang, H., Cao, L., Shan, L., Zhao, Y., Li, K., Hao, Y., et al. (2021) · Results in Physics · doi:10.1016/j.rinp.2021.104305 · Cited by 5 · see citing works

Highlighting the impact of social relationships on the propagation of respiratory viruses using percolation theory

Mathiot, J.-F., Gerbaud, L., & Breton, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-03812-9 · Cited by 5 · see citing works

The phase dynamics of the COVID-19 pandemic: a systematic analysis of 213 Countries and Territories

The Nano City Holdings Berhad, N. 1., & Teppone, M. (2022) · Problems of Social Hygiene Public Health and History of Medicine · doi:10.32687/0869-866x-2022-30-3-347-355 · Cited by 4 · see citing works

The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics

Dimeglio, C., Loubes, J., Miédougé, M., Hérin, F., Soulat, J., & Izopet, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-92131-0 · Cited by 4 · see citing works

Undetected and Relatively Sustained Severe Acute Respiratory Syndrome Coronavirus 2 Circulation Worldwide During 2019

Petti, S. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab727 · Cited by 4 · see citing works

Serological investigation of SARS-CoV-2 infection in patients with suspect measles, 2017–2022

Bianchi, S., Fappani, C., Gori, M., Canuti, M., Colzani, D., Monti, M. C., Torriani, C., Raviglione, M. C., Zuccotti, G., Tanzi, E., et al. (2023) · Virology Journal · doi:10.1186/s12985-023-02117-9 · Cited by 2 · see citing works

Do variations in anomalous mortality in Europe in fall and winter of 2019–2020 tell us anything on the timing of SARS‐CoV‐2 outbreak?

Śleszyński, P., Kurek, S., Krzysztofik, R., & Owsiński, J. W. (2023) · Population Space and Place · doi:10.1002/psp.2724 · Cited by 2 · see citing works

The Benefit of Augmenting Open Data with Clinical Data-Warehouse EHR for Forecasting SARS-CoV-2 Hospitalizations in Bordeaux Area, FrancePreprint

Ferté, T., Jouhet, V., Griffier, R., Hejblum, B. P., Thiébaut, R., & Task, A. C. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4071506 · Cited by 2 · see citing works

Re: Carrat et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort

Samuel, A. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00925-x · Cited by 2 · see citing works

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison

Penel, N., Cantarel, C., Chemin-Airiau, C., Ducimetière, F., Gouin, F., Loarer, F. L., Toulmonde, M., Piperno-Neumann, S., Bellera, C. A., Honoré, C., et al. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231192400 · Cited by 1 · see citing works

Epidemiology of COVID-19 in Latin America

Rodriguez-Morales, A. J., & Bonilla‐Aldana, D. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85662-1.00012-4 · Cited by 1 · see citing works

Respiratory illness of unknown cause as an early signal of the COVID-19 pandemic

Chen, R., Kunasekaran, M. P., Moa, A., Lim, S., Chughtai, A. A., Kpozehouen, E. B., Chen, X., Quigley, A. L., & MacIntyre, C. R. (2024) · Global Biosecurity · doi:10.31646/gbio.253 · Cited by 1 · see citing works

Why the Official Theory about COVID-19 Is Not Tenable

Franchi, F. (2025) · International Journal of Vaccine Theory Practice and Research · doi:10.56098/vdwyqd57 · Cited by 1 · see citing works

Épidémiologie de la COVID-19, focus sur le pôle de gériatrie des hôpitaux universitaires de Strasbourg

Cavée, L., & Kaltenbach, G. (2021) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2021.05.008 · Cited by 1 · see citing works

Revisiting Metchnikoff's work in light of the COVID-19 pandemic

Cavaillon, J., & Levin, J. (2022) · Innate Immunity · doi:10.1177/17534259211070663 · Cited by 1 · see citing works

Pre-SARS-CoV-2 Human Sera Reacts with Peptides from All the 7 Human Coronaviruses: Peptide Microarray IgM and IgG ScreeningPreprint

Ashworth, J., Mathie, D., Scott, F., Mahendran, Y., Woolhouse, M. E. J., Stoevesandt, O., Mduluza, T., & Mutapi, F. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4010886 · Cited by 1 · see citing works

Four Futures for U.S. Pandemic PolicyPreprint

Hemel, D. J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3846871

Comments on COVID-19, a double-edged sword for the environment: a review on the impacts of COVID-19 on the environment

Mohideen, M. M., & Liu, Y. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17979-1

Ce que la Covid-19 nous apprend sur la modélisation des épidémies

Mathiot, J.-F., Gerbaud, L., & Breton, V. (2022) · Reflets de la physique · doi:10.1051/refdp/202273022

Conserver le vivant

(2022) · doi:10.3917/edmat.guche.2022.01.0317

The Authors' Reply

Carrat, F., Desenclos, J. C., de Lamballerie, X. N., & Zins, M. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00927-9

Narratív bűnbakképzés a pandémia alatt : Kit/mit és miért okolunk a koronavírusért?

Bobák, S. (2021) · Tabula · doi:10.54742/tabula.2021.2.02

Can Some Viral Respiratory Infections Observed Before the Pandemic Announcement Be Related to SARS-CoV-2?

Alpaydın, A. Ö., Appak, Ö., Gezer, N. S., Yiğit, S., Karayazı, D. G., Kuruüzüm, Z., Şi̇mşek, G. Ö., Kutsoylu, O. Ö. E., Sayıner, A. A., Sevinç, C., et al. (2023) · Thoracic research and practice · doi:10.5152/thoracrespract.2023.22187

Emergency department CT examinations demonstrate no evidence of early viral circulation at the start of the COVID-19 pandemic—a multicentre epidemiological study

Crombé, A., Dupont, C., Casalonga, F., Seux, M., Favard, N., Coulon, A., Jurkovic, T., Nivet, H., & Gorincour, G. (2024) · Insights into Imaging · doi:10.1186/s13244-023-01590-8

Modalités de contamination des étudiants au SARS-CoV-2 dans l’université Clermont Auvergne

Gerbaud, L., Borie, C., Kriche, A., Gautier, N., Issartel-Filiol, O., Shoïjinimaeva, A., & Chabanas, B. (2024) · La Revue de Santé Scolaire et Universitaire · doi:10.1016/j.revssu.2024.10.006

CONSTANCES, the French nationwide population cohort: major accomplishments

Zins, M., Goldberg, M., Kab, S., Siemiatycki, J., Duclos, A., Constances Team, Airagnes, G., Baylet, M., Bonnaud, S., Bouziri, H., et al. (2026) · European Journal of Epidemiology · doi:10.1007/s10654-026-01463-6

What the COVID-19 pandemic teaches us about modelling epidemics: Percolation versus SEIRPreprint

Mathiot, J.-F., Gerbaud, L., & Breton, V. (2025) · medRxiv · doi:10.1101/2025.11.13.25340147

Additional file 4 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

Liu, J., Chen, X., Liu, Y., Lin, J., Shen, J., Zhang, H., Yin, J., Pu, R., Ding, Y., & 曹广文 (2021) · Figshare · doi:10.6084/m9.figshare.16305781

Additional file 1 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

Liu, J., Chen, X., Liu, Y., Lin, J., Shen, J., Zhang, H., Yin, J., Pu, R., Ding, Y., & 曹广文 (2021) · Figshare · doi:10.6084/m9.figshare.16305772

Additional file 2 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

Liu, J., Chen, X., Liu, Y., Lin, J., Shen, J., Zhang, H., Yin, J., Pu, R., Ding, Y., & 曹广文 (2021) · Figshare · doi:10.6084/m9.figshare.16305775

Additional file 5 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

Liu, J., Chen, X., Liu, Y., Lin, J., Shen, J., Zhang, H., Yin, J., Pu, R., Ding, Y., & 曹广文 (2021) · Figshare · doi:10.6084/m9.figshare.16305784

Additional file 3 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

Liu, J., Chen, X., Liu, Y., Lin, J., Shen, J., Zhang, H., Yin, J., Pu, R., Ding, Y., & 曹广文 (2021) · Figshare · doi:10.6084/m9.figshare.16305778

Additional file 1 of Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients

Dupont, A., Couffignal, C., Arias, C., Sallah, K., Phillips-Houlbracq, M., Brun, M. L., & Taillé, C. (2024) · Figshare · doi:10.6084/m9.figshare.26553845

Additional file 6 of Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein

Liu, J., Chen, X., Liu, Y., Lin, J., Shen, J., Zhang, H., Yin, J., Pu, R., Ding, Y., & 曹广文 (2021) · Figshare · doi:10.6084/m9.figshare.16305787

Bayesian neural networks enable inference of complex phylodynamic processesPreprint

Marino, G., Stolz, U., Agüí, C. V., Stadler, T., & Silvestro, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.03.703458

De l'origine des maladies : la médecine environnementale : une nouvelle grille de lecture

Reis, J. J. (2022) · doi:10.70675/b037ce62z054bz4048z9f93ze0a70c6c1357

Re: Carrat et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based “CONSTANCES” cohort

Samuel, A. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00925-x · Cited by 2 · see citing works

Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort–EPICOV

Warszawski, J., Meyer, L., Franck, J.-E., Rahib, D., Lydié, N., Gosselin, A., Counil, É., Kreling, R., Novelli, S., Slama, R., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267725 · Cited by 29 · see citing works

Undetected and Relatively Sustained Severe Acute Respiratory Syndrome Coronavirus 2 Circulation Worldwide During 2019

Petti, S. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab727 · Cited by 4 · see citing works

Hospital and Population-Based Evidence for COVID-19 Early Circulation in the East of France

Gerbaud, L., Guiguet‐Auclair, C., Breysse, F., Odoul, J., Ouchchane, L., Peterschmitt, J., Dezfouli-Desfer, C., & Breton, V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197175 · Cited by 30 · see citing works

SARS-CoV-2 was already circulating in Italy, in early December 2019.

(2021) · PubMed · doi:10.26355/eurrev_202104_25746 · Cited by 12 · see citing works